Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
Recombinant human activated protein C: current insights into its mechanism of action.
Levi M, van der Poll T
Crit Care 2007, 11 Suppl 5:S3
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

BioMed Central articles that cite the above article:

1.
37%37%


 Research    
Early drotrecogin alpha (activated) administration in severe sepsis is associated with lower mortality: a retrospective analysis of the Canadian ENHANCE cohort
Hodder RV, Hall R, Russell JA, Fisher HN, Lee B
Critical Care 2009, 13:R78 (20 May 2009)
 [Abstract] [Full text] [PDF] [PubMed] [Related articles]
2.
37%37%

 Commentary   
Recombinant human activated protein C in acute lung injury: what is the role of bronchial circulation?
Maybauer MO, Traber DL, Maybauer DM
Critical Care 2009, 13:112 (23 January 2009)
 [Abstract] [Full text] [PDF] [PubMed] [Related articles]
3.
37%37%


 Introduction    
Introduction: severe sepsis and drotrecogin alfa (activated)
Artigas A, Martin CD
Critical Care 2007, 11(Suppl 5):S1 (19 December 2007)
 [Full text] [PDF] [PubMed] [Related articles]

You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.